Key Publications

Baaj, L., Malamud, G., Argote, M., Gurbanova, A., Quaiattini, A., & Rabin, R. A. (2026). Investigating the relationship between cannabis abstinence and affective symptoms: A systematic review. Current Addiction Reports, 13(1). 

Rabin, R. A. (2026). Special issue: The harms and benefits of cannabis and cannabinoids in women and men and effects on their progeny. Drug and Alcohol Dependence Reports, 18, 100409.

Ferland, G., Argote, M., Gitelman, E., Rabin, R. (2026). Recovery of cognitive impairments associated with chronic cannabis use following cannabis cessation: Evidence from a prospective abstinence paradigm. Neuropsychopharmacology 51(Suppl 1). 

Yeap, Z. J. S., Argote, M., Nadler, E., He, P., Parvaz, M. A., Rabin, R. A. (2026). Cannabis and nicotine/tobacco co-use and its association with cognitive and neural outcomes: A systematic review. Neuroscience and Biobehavioral Reviews, 180. 

Kim, E. H., Yin, A. P. X., Merenda, F., Cuddleston, K., Wein, P. Y., Delbourgo Patton, C., George, T. P., Rabin, R. A., Weinberger, A. H. (2025). Cannabis and cognition in schizophrenia: systematic review of research published from 2011 To 2024. Current Addiction Reports, 12(1). 

McClure, E. A., Piper, M. E., Crotty Alexander, L. E., Burnham, E. L., Freeman, T. P., Galiatsatos, P., Lang, A. E., Lee, D. C., Leone, F. T., Melzer, A. C., Mermelstein, R. J., Montgomery, L., Rabin, R. A., Smith, D. M., StHelen, G., Weinberger, A. H.,  Kathuria, H. (2025). Effects of inhaled tobacco and cannabis co-use on respiratory health and tobacco cessation: An official american thoracic society research statement. American Journal of Respiratory and Critical Care Medicine, 211(11), 2021–2042. 

Bello, D., Blyth, S. H., Rabin, R. A., Addington, J., Bearden, C. E., Cadenhead, K., Cannon, T. D., Carrión, R. E., Cornblatt, B., Keshavan, M., Mathalon, D. H., Perkins, D. O., Seidman, L., Stone, W. S., Tsuang, M. T., Walker, E. F., Woods, S., Brady, R. O., Jr, Ward, H. B. (2025). Cannabis and tobacco co-use predicts psychosis in clinical high risk cohorts. medRxiv.

Rabin, R. A., Lerman, C., Schnoll, R., Tyndale, R. F., George, T. P. (2025). A multi-site study examining the tobacco withdrawal trajectory in people with tobacco and cannabis co-use. Drug and Alcohol Dependence, 274, 112778.

Argote, M., Hilson, L., Sorkhou, M., & Rabin, R. A. (2025). A systematic review investigating prenatal cannabis and tobacco co-exposure: Impacts on neonatal, behavioral, cognitive and physiological outcomes. Drug and Alcohol Dependence Reports, 17. 

Rabin, R. A., Farrugia, J., Garani, R., Mizrahi, R., Rusjan, P. (2025). A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use. Drug and Alcohol Dependence Reports, 16. 

Ahrens, J., Ford, S. D., Schaefer, B., Reese, D., Khan, A. R., Tibbo, P., Rabin, R. A., Cassidy, C. M., Palaniyappan, L. (2025). Convergence of cannabis and psychosis on the dopamine system. JAMA Psychiatry, 82(6), 609–617. 

Ahrens, J., Zaher, F., Rabin, R. A., Cassidy, C. M., Palaniyappan, L. (2024). Neuromelanin levels in individuals with substance use disorders: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 161, 105690. 

Ahrens, J., Zaher, F., Rabin, R. A., Cassidy, C. M., Palaniyappan, L. (2025). Corrigendum to “Neuromelanin levels in individuals with substance use disorders: A systematic review and meta-analysis” Neurosci. Biobehav. Rev. 161 (2024) 105690. Neuroscience and Biobehavioral Reviews, 172. 

Yeap, Z. J. S., Juliano, A., Pancholi, D., Filbey, F., Garava, H., Yucel, M., Lorenzetti, V., Solowij, N., Martin-Santos, R., Batalla, A., Cousijn, J., London, E., Zhang, X., Rabin, R. A. (2025). Cannabis and tobacco co-use and its association with striatal brain morphometry: Leveraging data from the enigma addiction working group. Drug and Alcohol Dependence, 267.

Baaj, L., Malamud, G., Rabin, R. A. (2025). Effects of sustained cannabis abstinence on depressive symptoms in people with cannabis use disorder. Drug and Alcohol Dependence, 267, 111628. 

Nadler, E., Jacobus, J., & Rabin, R. A. (2025). Prenatal cannabis and tobacco co-exposure and its association with behavioural outcomes in middle childhood: Co-exposition prénatale au cannabis et au tabac et son association avec les résultats comportementaux au cours de l’enfance intermédiaire. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 70(1), 41–53. 

Sorkhou, M., Johnstone, S., Weinberger, A. H., Cooper, Z. D., Sanches, M., Castle, D. J., Hall, W., Rabin, R. A., Hammond, D.,  George, T. P. (2024). Changes in cannabis use patterns in psychiatric populations pre- and post-legalization of recreational cannabis use in Canada: A repeated cross-sectional survey. Cannabis (Albuquerque, N.M.), 7(3), 1–13. 

Malamud, G., Baaj, L., Hanna, S., Argote, M., Rabin, R. A. (2024). Are there sex differences in the cannabis withdrawal trajectory during 28 days of cannabis abstinence? Neuropsychopharmacology, 49(Suppl 1), 270.

Ahrens, J., Ford, S. D., Schaefer, B., Reese, D., Khan, A. R., Tibbo, P., Rabin, R. A., Cassidy, C. M., Palaniyappan, L. (2025). Convergence of cannabis and psychosis on the dopamine system. JAMA Psychiatry. 

Yeap, Z. J. S., Baaj, L., George, T. P., Mizrahi, R.,  Rabin, R. A. (2024). Characterizing the cannabis withdrawal trajectory in men with cannabis and tobacco co-use: A preliminary study. Canadian Journal of Addiction, 15(3), 46–55. 

Johnstone, S., Sorkhou, M., Zhang, M., Dermody, S. S., Rabin, R. A., George, T. P. (2024). Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies. The American Journal of Drug and Alcohol Abuse, 50(1), 95–105. 

Rabin, R. A., Garani, R., Kojok, L., Rusjan, P., Mizrahi, R. (2023). A novel investigation of tobacco co-use on endocannabinoid activity in people with cannabis use. Neuropsychopharmacology, 48(Suppl 1), 407.

Rabin, R. A., Palaniyappan, L. (2023). Brain health in ethnically minority youth at risk for psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 48(12), 1701–1702. 

Argote, M., Sescousse, G., Brunelin, J., Baudin, G., Schaub, M. P., Rabin, R. A., Schnell, T., Ringen, P. A., Andreassen, O. A., Addington, J. M., Brambilla, P., Delvecchio, G., Bechdolf, A., Wobrock, T., Schneider-Axmann, T., Herzig, D., Mohr, C., Vila-Badia, R., Rodie, J. U., et al. (2023). Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals. eClinicalMedicine, 64. 

Wipf, N., Rabin, R. A., Pappas, J. (2023). Building a registry for SETD2 neurodevelopmental disorder. Irish Journal of Medical Science, 192(Suppl 1), S10.

Rabin, R. A., McClure, E. A., & George, T. P. (2023). Tobacco use among individuals with cannabis use. In Marijuana and madness (pp. 310–320). Cambridge University Press.

Zhang, Y., Johnstone, S., Sorkhou, M., Dermody, S., Rabin, R. A., George, T. (2023). Cannabis cravings predict compensatory increases in cigarette use in schizophrenia: Findings from cannabis abstinence studies. Biological Psychiatry, 93(9 Suppl.), S225.

Zhang, Y., Johnstone, S., Sorkhou, M., Dermody, S., Rabin, R. A., George, T. (2023). 325. Cannabis Cravings Predict Compensatory Increases in Cigarette Use in Schizophrenia: Findings From Cannabis Abstinence Studies. Biological Psychiatry, 93(9), S225. 

Yeap ZJS, Marsault J, George TP, Mizrahi R, Rabin RA. (2023). Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders? The American Journal on Addictions, 1-9.

Rabin RA, Parvaz MA, Alia-Klein N, Goldstein RZ. (2022). Emotion Recognition in Individuals with Cocaine Use Disorder: the Role of Abstinence Length and the Social Brain Network. Psychopharmacology, 239(4):1019-1033. 

Rabin RA, Mackey S, Parvaz MA, Cousijn J, Li CS, Pearlson G, Schmaal L, Sinha R, Stein E, Veltman D, Thompson PM, Conrod P, Garavan H, Alia-Klein N, Goldstein RZ. (2022). Common and Gender-Specific Associations with Cocaine Use on Gray Matter Volume: Data from the ENIGMA Addiction Working Group. Human brain mapping, 43(1):543-554.

Rabin RA. Commentary on Walsh et al. (2020): Tobacco and Cannabis Co-Use— Considerations for Treatment. Addiction, 115(10):1815-1816.

Rabin RA, Dermody SS, George TP. (2018) Changes in Tobacco Consumption in Cannabis Dependent Patients with Schizophrenia Versus Non-Psychiatric Controls During 28-Days of Cannabis Abstinence. Drug and alcohol dependence, 185:181-188. 

Rabin RA, Kozak K, Zakzanis KK, Remington G, Stefan C, Budney AJ, George TP. (2018). A Method to Achieve Extended Cannabis Abstinence in Cannabis Dependent Patients with Schizophrenia and Non-Psychiatric Controls. Schizophrenia research, 194, 47-54.

Rabin RA, Kozak K, Zakzanis KK, Remington G, George TP (2018). Effects of Extended Cannabis Abstinence on Clinical Symptoms in Cannabis Dependent Schizophrenia Patients Versus Non-Psychiatric Controls. Schizophrenia Research, 194, 55-61.

Rabin RA, Barr MS, Goodman MS, Herman Y, Kiang M, Zakzanis KK, Kish SJ, Remington G, George TP (2017). Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Schizophrenia Patients and Non-Psychiatric Controls. Neuropsychopharmacology, 42, 2259-2271.

Rabin RA and George TP (2015). A Review of Co-Morbid Tobacco and Cannabis Use Disorders: Possible Mechanisms to Explain the High Rates of Co-Use. The American Journal on Addictions, 24, 105-116.

Rabin RA, Zakzanis KK, Daskalakis ZJ, George TP (2013). Effects of Cannabis Use Status on Cognitive Function in Males, with Schizophrenia. Psychiatry Research, 206, 158-165.

Rabin RA, Zakzanis KK, George TP (2011). Effects of Cannabis Use on Neurocognition in Schizophrenia: A Meta-Analysis. Schizophrenia Research, 128, 111-116.